tiprankstipranks
Trending News
More News >
CStone Pharmaceuticals (HK:2616)
:2616
Hong Kong Market

CStone Pharmaceuticals (2616) Financial Statements

Compare
4 Followers

CStone Pharmaceuticals Financial Overview

CStone Pharmaceuticals's market cap is currently HK$8.41B. The company's EPS TTM is HK$-0.23461668719999998; its P/E ratio is -18.58; CStone Pharmaceuticals is scheduled to report earnings on August 14, 2025, and the estimated EPS forecast is HK$-0.01. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 407.20M¥ 463.84M¥ 481.36M¥ 243.72M¥ 1.04B
Gross Profit¥ 240.15M¥ 304.30M¥ 278.38M¥ 136.89M¥ 797.41M
Operating Income¥ -91.69M¥ -605.57M¥ -912.15M¥ -1.83B¥ -1.09B
EBITDA¥ -76.43M¥ -297.23M¥ -849.66M¥ -1.90B¥ -1.20B
Net Income¥ -91.21M¥ -367.23M¥ -902.68M¥ -1.92B¥ -1.22B
Balance Sheet
Cash & Short-Term Investments¥ 672.94M¥ 1.05B¥ 1.04B¥ 1.73B¥ 3.39B
Total Assets¥ 1.39B¥ 1.66B¥ 1.64B¥ 2.27B¥ 3.76B
Total Debt¥ 355.97M¥ 363.45M¥ 286.29M¥ 174.20M¥ 83.86M
Net Debt¥ -31.96M¥ -633.22M¥ -272.39M¥ -568.53M¥ -2.94B
Total Liabilities¥ 1.03B¥ 1.21B¥ 1.19B¥ 1.06B¥ 808.29M
Stockholders' Equity¥ 363.87M¥ 456.83M¥ 449.33M¥ 1.21B¥ 2.95B
Cash Flow
Free Cash Flow¥ -343.18M¥ -653.89M¥ -714.29M¥ -1.63B¥ -579.52M
Operating Cash Flow¥ -343.18M¥ -588.84M¥ -612.47M¥ -1.48B¥ -508.07M
Investing Cash Flow¥ -247.68M¥ 619.61M¥ 365.12M¥ -826.55M¥ 1.18B
Financing Cash Flow¥ -12.90M¥ 388.36M¥ 28.47M¥ 92.30M¥ 1.39B
Currency in CNY

CStone Pharmaceuticals Earnings and Revenue History

CStone Pharmaceuticals Debt to Assets

CStone Pharmaceuticals Cash Flow

CStone Pharmaceuticals Forecast EPS vs Actual EPS